185 related articles for article (PubMed ID: 21869822)
1. Neoadjuvant in situ gene-mediated cytotoxic immunotherapy improves postoperative outcomes in novel syngeneic esophageal carcinoma models.
Predina JD; Judy B; Aliperti LA; Fridlender ZG; Blouin A; Kapoor V; Laguna B; Nakagawa H; Rustgi AK; Aguilar L; Aguilar-Cordova E; Albelda SM; Singhal S
Cancer Gene Ther; 2011 Dec; 18(12):871-83. PubMed ID: 21869822
[TBL] [Abstract][Full Text] [Related]
2. Adenovirus vector-mediated herpes simplex virus-thymidine kinase gene/ganciclovir system exhibits anti-tumor effects in an orthotopic hepatocellular carcinoma model.
Zhu R; Chen D; Lin D; Lu F; Yin J; Li N
Pharmazie; 2014 Jul; 69(7):547-52. PubMed ID: 25073402
[TBL] [Abstract][Full Text] [Related]
3. Adenovirus-mediated suicide gene therapy for experimental bladder cancer.
Sutton MA; Berkman SA; Chen SH; Block A; Dang TD; Kattan MW; Wheeler TM; Rowley DR; Woo SL; Lerner SP
Urology; 1997 Feb; 49(2):173-80. PubMed ID: 9037277
[TBL] [Abstract][Full Text] [Related]
4. Neoadjuvant Gene-Mediated Cytotoxic Immunotherapy for Non-Small-Cell Lung Cancer: Safety and Immunologic Activity.
Predina JD; Haas AR; Martinez M; O'Brien S; Moon EK; Woodruff P; Stadanlick J; Corbett C; Frenzel-Sulyok L; Bryski MG; Eruslanov E; Deshpande C; Langer C; Aguilar LK; Guzik BW; Manzanera AG; Aguilar-Cordova E; Singhal S; Albelda SM
Mol Ther; 2021 Feb; 29(2):658-670. PubMed ID: 33160076
[TBL] [Abstract][Full Text] [Related]
5. Exogenous p53 and ASPP2 expression enhances rAdV-TK/ GCV-induced death in hepatocellular carcinoma cells lacking functional p53.
Liu X; Wang S; Guo X; Wei F; Yin J; Zang Y; Li N; Chen D
Oncotarget; 2016 Apr; 7(14):18896-905. PubMed ID: 26934443
[TBL] [Abstract][Full Text] [Related]
6. Prostate cancer gene therapy: herpes simplex virus thymidine kinase gene transduction followed by ganciclovir in mouse and human prostate cancer models.
Eastham JA; Chen SH; Sehgal I; Yang G; Timme TL; Hall SJ; Woo SL; Thompson TC
Hum Gene Ther; 1996 Mar; 7(4):515-23. PubMed ID: 8800746
[TBL] [Abstract][Full Text] [Related]
7. Pancreatic carcinoma cell killing via adenoviral mediated delivery of the herpes simplex virus thymidine kinase gene.
Rosenfeld ME; Vickers SM; Raben D; Wang M; Sampson L; Feng M; Jaffee E; Curiel DT
Ann Surg; 1997 May; 225(5):609-18; discussion 618-20. PubMed ID: 9193188
[TBL] [Abstract][Full Text] [Related]
8. Synergy between the herpes simplex virus tk/ganciclovir prodrug suicide system and the topoisomerase I inhibitor topotecan.
Wildner O; Blaese RM; Morris JC
Hum Gene Ther; 1999 Nov; 10(16):2679-87. PubMed ID: 10566896
[TBL] [Abstract][Full Text] [Related]
9. Differential chemosensitivity of breast cancer cells to ganciclovir treatment following adenovirus-mediated herpes simplex virus thymidine kinase gene transfer.
Li PX; Ngo D; Brade AM; Klamut HJ
Cancer Gene Ther; 1999; 6(2):179-90. PubMed ID: 10195885
[TBL] [Abstract][Full Text] [Related]
10. Adenovirus-mediated herpes simplex virus thymidine kinase gene therapy in BT4C rat glioma model.
Tyynelä K; Sandmair AM; Turunen M; Vanninen R; Vainio P; Kauppinen R; Johansson R; Vapalahti M; Ylä-Herttuala S
Cancer Gene Ther; 2002 Nov; 9(11):917-24. PubMed ID: 12386830
[TBL] [Abstract][Full Text] [Related]
11. Differential efficacy of suicide gene therapy by herpes simplex virus-thymidine kinase gene reflects the status of p53 gene in human esophageal cancer cells.
Matsubara H; Kawamura K; Sugaya M; Koide Y; Gunji Y; Takenaga K; Asano T; Ochiai T; Sakiyama S; Tagawa M
Anticancer Res; 1999; 19(5B):4157-60. PubMed ID: 10628368
[TBL] [Abstract][Full Text] [Related]
12. Experimental study of the RV-HSV-TK/GCV suicide gene therapy system in gastric cancer.
Tang Q; Zhang D; Wan M; Jin L
Cancer Biother Radiopharm; 2007 Dec; 22(6):755-61. PubMed ID: 18158766
[TBL] [Abstract][Full Text] [Related]
13. Double-Dose Adenovirus-Mediated Adjuvant Gene Therapy Improves Liver Transplantation Outcomes in Patients with Advanced Hepatocellular Carcinoma.
Zhu R; Weng D; Lu S; Lin D; Wang M; Chen D; Lv J; Li H; Lv F; Xi L; Zhou J; Ma D; Li N
Hum Gene Ther; 2018 Feb; 29(2):251-258. PubMed ID: 29446997
[TBL] [Abstract][Full Text] [Related]
14. Adenovirus-mediated gene therapy in an experimental model of breast cancer metastatic to the brain.
Colak A; Goodman JC; Chen SH; Woo SL; Grossman RG; Shine HD
Hum Gene Ther; 1995 Oct; 6(10):1317-22. PubMed ID: 8590736
[TBL] [Abstract][Full Text] [Related]
15. Retrovirus-mediated herpes simplex virus thymidine kinase gene transduction renders human thyroid carcinoma cell lines sensitive to ganciclovir and radiation in vitro and in vivo.
Nishihara E; Nagayama Y; Mawatari F; Tanaka K; Namba H; Niwa M; Yamashita S
Endocrinology; 1997 Nov; 138(11):4577-83. PubMed ID: 9348181
[TBL] [Abstract][Full Text] [Related]
16. Enhanced therapeutic effect of multiple injections of HSV-TK + GCV gene therapy in combination with ionizing radiation in a mouse mammary tumor model.
Vlachaki MT; Chhikara M; Aguilar L; Zhu X; Chiu KJ; Woo S; Teh BS; Thompson TC; Butler EB; Aguilar-Cordova E
Int J Radiat Oncol Biol Phys; 2001 Nov; 51(4):1008-17. PubMed ID: 11704325
[TBL] [Abstract][Full Text] [Related]
17. Treatment of malignant gliomas with a replicating adenoviral vector expressing herpes simplex virus-thymidine kinase.
Nanda D; Vogels R; Havenga M; Avezaat CJ; Bout A; Smitt PS
Cancer Res; 2001 Dec; 61(24):8743-50. PubMed ID: 11751394
[TBL] [Abstract][Full Text] [Related]
18. Systemic administration of radiation-potentiated anti-angiogenic gene therapy against primary and metastatic cancer based on transcriptionally controlled HSV-TK.
Hodish I; Tal R; Shaish A; Varda-Bloom N; Greenberger S; Rauchwerger A; Breitbart E; Bangio L; Ben-Shushan D; Pfeffer R; Feder B; Waitsman A; Barshack I; Goldberg I; Mazaki-Tovi S; Peled M; Harats D
Cancer Biol Ther; 2009 Mar; 8(5):424-32. PubMed ID: 19276657
[TBL] [Abstract][Full Text] [Related]
19. Combined suicide and cytokine gene therapy for peritoneal carcinomatosis.
Lechanteur C; Delvenne P; Princen F; Lopez M; Fillet G; Gielen J; Merville MP; Bours V
Gut; 2000 Sep; 47(3):343-8. PubMed ID: 10940269
[TBL] [Abstract][Full Text] [Related]
20. Combined suicide gene and immunostimulatory gene therapy using AAV-mediated gene transfer to HPV-16 transformed mouse cell: decrease of oncogenicity and induction of protection.
Janousková O; Síma P; Kunke D
Int J Oncol; 2003 Mar; 22(3):569-77. PubMed ID: 12579310
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
